WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011017395) CHEMICAL COMPOUNDS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/017395    International Application No.:    PCT/US2010/044347
Publication Date: 10.02.2011 International Filing Date: 04.08.2010
IPC:
A01N 43/40 (2006.01), A61K 31/36 (2006.01)
Applicants: GLAXOSMITHKLINE LLC [US/US]; One Franklin Plaza 200 North 16th Street Philadelphia, Pennsylvania 19102 (US) (For All Designated States Except US).
JOHNS, Brian Alvin [US/US]; (US) (For US Only).
TEMELKOFF, David P. [US/US]; (US) (For US Only).
VELTHUISEN, Emile Johann [US/US]; (US) (For US Only).
WEATHERHEAD, Jason Gordon [US/US]; (US) (For US Only)
Inventors: JOHNS, Brian Alvin; (US).
TEMELKOFF, David P.; (US).
VELTHUISEN, Emile Johann; (US).
WEATHERHEAD, Jason Gordon; (US)
Agent: CARTER, Barbara J.; c/o GlaxoSmithKline Global Patents Dept. Five Moore Drive P. O. Box 13398 Research Triangle Park, North Carolina 27709 (US)
Priority Data:
61/231,217 04.08.2009 US
Title (EN) CHEMICAL COMPOUNDS
(FR) COMPOSÉS CHIMIQUES
Abstract: front page image
(EN)The present invention relates to highly functionalized 1,3-diamino-propan-2-ols and pharmaceutically acceptable salts thereof. More specifically, the invention relates to highly functionalized 1,3-diamino-propan-2-ols that are derivatives of the HIV protease inhibitors darunavir.
(FR)La présente invention porte sur des 1,3-diamino-propan-2-ols hautement fonctionnalisés et sur des sels pharmaceutiquement acceptables de ceux-ci. Plus spécifiquement, l'invention porte sur des 1,3-diamino-propan-2-ols hautement fonctionnalisés qui sont des dérivés des inhibiteurs de protéase du VIH à base de darunavir.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)